您的位置: 首页 > 农业专利 > 详情页

Method for evaluating side-effect onset risk in anticancer drug treatment, including detecting MUC4 gene polymorphism
专利权人:
SAITAMA MEDICAL UNIVERSITY
发明人:
Koichi Hagiwara,Hitoshi Miyazawa,Jun Shiihara,Tomoaki Tanaka,Yoshiaki Inoue
申请号:
US14771465
公开号:
US09873920B2
申请日:
2014.02.27
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The purpose of the present invention is to provide an evaluation method kit for evaluating the risk of onset of diffuse alveolar damage due to such factors as anticancer drug administration. The purpose of the present invention is also to provide a method for evaluating the risk of onset of side effects in anticancer drug treatment. An evaluation method and evaluation kit for evaluating the risk of onset of diffuse alveolar damage, including detecting gene polymorphism present in the MUC4 gene. A method for evaluating the risk of onset of side effect in anticancer drug treatment, including detecting gene polymorphism present in the MUC4 gene of a patient scheduled for anticancer drug administration.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充